Driehaus Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-49,606
Closed -$6.33M 512
2019
Q1
$6.33M Sell
49,606
-16,942
-25% -$2.15M 0.24% 117
2018
Q4
$8.32M Sell
66,548
-37,097
-36% -$6.35M 0.36% 78
2018
Q3
$23M Buy
103,645
+13,218
+15% +$2.68M 0.71% 26
2018
Q2
$14.5M Buy
90,427
+13,595
+18% +$1.74M 0.49% 46
2018
Q1
$7.18M Buy
76,832
+29,632
+63% +$2.21M 0.25% 102
2017
Q4
$3.29M Buy
+47,200
New +$3.13M 0.13% 205

Other funds holding MED

Driehaus Capital Management's MED Position: Q2 2019 in Review

Driehaus Capital Management sold out of Medifast (MED) in Q2 2019, closing a stake of 49,606 shares — an estimated $6.33M sold.

Driehaus Capital Management first reported a position in MED in Q4 2017 and held it in 6 quarters. The position peaked at $23M in Q3 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

  • Driehaus Capital Management reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
  • Driehaus Capital Management sold 49,606 Medifast shares in Q2 2019, an estimated $6.33M.
  • Driehaus Capital Management first reported a position in Medifast in Q4 2017 and held it in 6 quarters.
  • Driehaus Capital Management's Medifast position peaked at $23M in Q3 2018.
  • 251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on Driehaus Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.